EMMALEIGH MONDELL: Open Payments
NPI 1205602273 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 30 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $583 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $195 |
| ABBVIE INC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Hologic Sales and Service, LLC | 1 | $35 |
| Lilly USA, LLC | 2 | $34 |
| PFIZER INC. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Biogen, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: Ozempic, VRAYLAR, TRELEGY ELLIPTA, APTIMA, MOUNJARO, Rybelsus, FARXIGA, SPRAVATO.
Industry payments across VA — which companies pay providers there.
